Alfonso Gomez de Liano Lista, MD, on KEYNOTE-B15 quality of life: no difference between arms in MIBC; scores recovered after cystectomy in both arms, except sexual function. #ESMO2

OncologyEducation· @OncEd · X·2026-10-25 06:56· 18 hours agoScore70

Body · original

Alfonso Gomez de Liano Lista, MD, on KEYNOTE-B15 quality of life: no difference between arms in MIBC; scores recovered after cystectomy in both arms, except sexual function. #ESMO26

Watch now: https://bit.ly/4ieoXGx

10 views · 0 likes · 0 reposts · 0 replies

Conference abstracts

4734Omatched by Proffered paper 1: Genitourinary tumour, renal and urothelial

ctDNA analysis of the Phase 3 KEYNOTE-B15 trial: neoadjuvant and adjuvant (neoadj-adj) enfortumab vedotin (EV) + pembrolizumab (pembro) for participants (pts) with muscle-invasive bladder cancer (MIBC) who are eligible for cisplatin

https://esmocongress.esmo.org

NCT04700124NCT04700124matched by - **标题 / Title：** Perioperative Enfortumab Vedotin (EV) Plus Pembrolizumab (MK-3475) Versus Neoadjuvant Chemotherapy for Cisplatin-Eligible Muscle Invasive Bladder Cancer (MIBC) (MK-3475-B15/ KEYNOTE-B15 / EV-304)

- **标题 / Title：** Perioperative Enfortumab Vedotin (EV) Plus Pembrolizumab (MK-3475) Versus Neoadjuvant Chemotherapy for Cisplatin-Eligible Muscle Invasive Bladder Cancer (MIBC) (MK-3475-B15/ KEYNOTE-B15 / EV-304)

https://esmocongress.esmo.org

Source: OncologyEducation · x.com